Truveta Data has already powered some of the most cutting-edge research on GLP-1s, including the largest comparative effectiveness study to date of tirzepatide (Mounjaro) vs
Oncol (Williston Park) 15(3 Suppl 5):1620 Hu Y, Du Y, Qiu Z, Zhu C, Wang J, Liang T et al (2024) Signal mining and analysis of trifluridine/tipiracil adverse events based on real-world data from the FAERS database
Typically 200600mg daily
Gastrointestinal tolerance : The most common adverse effectsnausea, vomiting, diarrhea, and constipationare dose-dependent and typically diminish over time
In TBI, the excessive glutamate release leads to an upregulation of these receptors, disrupting ion balance by allowing extracellular calcium and sodium ions into the cells (Meldrum, 2000)